Inventor
Kenneth M. Boy
Inventor
Durham, CT, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides13%
Y02ATechnologies for adaptation to climate change7%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C04BLime, magnesia3%
C07BGeneral methods of organic chemistry3%
A61BDiagnosis1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
11,103,605PET-imaging immunomodulators202110,633,419Immunomodulators20209,879,046'Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions'20189,856,292'Immunomodulators'20189,850,283Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions20179,833,454Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production20179,809,625'Immunomodulators'20179,308,236'Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions'20168,710,061'Compounds for the reduction of β-amyloid production'20148,637,525'Compounds for the reduction of beta-amyloid production'20148,637,523'Compounds for the reduction of beta-amyloid production'20148,486,952'Compounds for the reduction of β-amyloid production'20138,349,880'Bicyclic compounds for the reduction of beta-amyloid production'20137,981,913'Isophthalates as beta-secretase inhibitors'20117,902,218'Substituted tetrahydroisoquinolines as β-secretase inhibitors'20117,745,470'Isophthalates as beta-secretase inhibitors'20107,408,071'N-aryl pyrrolidine derivatives as beta-secretase inhibitors'20087,388,007'Gamma-lactams as beta-secretase inhibitors'20087,273,866'2-aryl thiazole derivatives as KCNQ modulators'20077,179,920'3-thia-4-arylquinolin-2-one derivatives'20077,173,004'Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus'20077,145,013'3-thia-4-arylquinolin-2-one derivatives'20067,132,542'Compounds for the treatment of male erectile dysfunction'20067,049,309'3-Thia-4-arylquinolin-2-one potassium channel modulators'20067,002,015'3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants'20066,933,308'Aminoalkyl thiazole derivatives as KCNQ modulators'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2021Patents assigned to BRISTOL MYERS SQUIBB CO (26)· patent assignee history
2005–2021Based in Durham, CT, US· patent location history
2013–2014Patents assigned to BOY KENNETH M (5)· patent assignee history
2013–2014Patents assigned to GUERNON JASON M (5)· patent assignee history
2013–2014Patents assigned to MACOR JOHN E (5)· patent assignee history
2013–2014Patents assigned to THOMPSON III LORIN A (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 26 | 2005–2021 |
| BOY KENNETH Mself | 5 | 2013–2014 |
| GUERNON JASON M | 5 | 2013–2014 |
| MACOR JOHN E | 5 | 2013–2014 |
| THOMPSON III LORIN A | 5 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Durham, CT, US | 26 | 2005–2021 |